MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopa-responsive dystonia(DRD)"

  • 2019 International Congress

    Clinical and genetic characteristics of a new mutation causing Segawa´s disease in a Spanish kindred

    J. Hernández-Vara, S. Lucas (Barcelona, Spain)

    Objective: To describe the clinical phenotype and genetic characteristics of a novel mutation causing Segawa´s disease in a Spanish family. Background: Dopa-Responsive Dystonia (DRD) is…
  • 2019 International Congress

    Pregnancy and Delivery Complications in Women with Inherited Isolated Dystonia

    M. San Luciano, V. Shanker, S. Bressman, D. Raymond, R. Saunders-Pullman (San Francisco, CA, USA)

    Objective: To determine whether female mutation carriers of inherited dopa-responsive (DRD) and DYT/TOR1A genes had higher pregnancy and delivery complications than non-carriers Background: Women with…
  • 2019 International Congress

    Atypical presentation of Dopa-responsive dystonia- late onset with severe swallowing difficulty

    C. Zhao, L. Li, H. Li, J. Zhang (Jinan, China)

    Objective: To learn about atypical presentation of Dopa-responsive dystonia (DRD) and give correct diagnose in time. Background: DRD compasses a group of clinically and genetically…
  • 2018 International Congress

    [11 C] DASB PET imaging in dopa-responsive dystonia patients: The role of serotonin in motor and non-motor symptoms

    E. Timmers, D. Vállez García, A. Bartels, A. Kuiper, R. Dierckx, M. Smit, M. Tijssen (Groningen, Netherlands)

    Objective: To assess the non-displaceable binding potential (BPND) of the serotonin transporter (SERT) in dopa-responsive dystonia (DRD) patients and to determine if an altered BPND…
  • 2018 International Congress

    The use of gliatilin in the complex treatment of vascular parkinsonism

    S. Lukmonov, D. Tolibov (Tashkent, Uzbekistan)

    Objective: In recent decades, as a result of increasing the life expectancy of the population, the number of patients with Parkinsonism has increased, which leads…
  • 2018 International Congress

    High dose of levodopa and Segawa disease

    M. Taghiyeva (Baku, Azerbaijan)

    Objective: To analyze the dose-dependent effects of levodopa on the symptoms of the disease in our case. Background: In 1976, Segawa et al. reported dopa-responsive…
  • 2018 International Congress

    Phenotypic Heterogeneity and Variability of Nigrostriatal Dopaminergic Function in a Dopa-Responsive Dystonia

    J.J. Lin (Nantou, Taiwan)

    Objective: To evaluate presynaptic nigrostriatal dopaminergic function in a Dopa-responsive dystonia (DRD) family with guanosine triphosphate cyclohydrolase 1 (GCH-1) mutation. Background: Mutation of GCH-1 located…
  • 2018 International Congress

    Neuropathology of dopa-responsive dystonia due to Tyrosine hydroxylase deficiency

    S. Schreglmann, Z. Jaunmuktane, H. Jung, C. Strand, J. Holton, K. Bhatia (London, United Kingdom)

    Objective: To describe detailed neuropathology findings from an autopsy case of dopa-responsive dystonia (DRD) with genetically confirmed tyrosine hydroxylase deficiency (THD). Background: DRD comprises a…
  • 2018 International Congress

    Molecular mechanisms of GCH1-associated Parkinson’s disease

    J. Terbeek, W. Vandenberghe (Leuven, Belgium)

    Objective: To unravel the molecular mechanisms by which loss of GCH1 function enhances the risk of Parkinson´s disease (PD). Background: Loss-of-function mutations in GCH1 are…
  • 2017 International Congress

    An unusual presentation of tyrosine hydroxylase deficiency

    L. Katus, S. Frucht (New York, NY, USA)

    Objective: To discuss a case of tyrosine hydroxylase deficiency presenting with resolution of symptoms on levodopa except for a dynamic segmental dystonia Background: Dopa-responsive dystonia…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley